Saltar al contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Lenguaje
Todos los Campos
Título
Autor
Materia
Número de Clasificación
ISBN/ISSN
Etiqueta
Buscar
Avanzado
Adalimumab sustains improvemen...
Citar
Describir
Enviar este por Correo electrónico
Imprimir
Exportar Registro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enlace Permanente
Adalimumab sustains improvement in spinal mobility in as patients through 104 weeks - Results from atlas
Detalles Bibliográficos
Autores principales:
Wordsworth, P
,
Dijkmans, B
,
van der Heijde, D
,
Davis, J
,
Schiff, M
,
Kivitz, A
,
Sieper, J
,
Mease, P
,
Kupper, H
,
Wong, R
,
Grp, A
Formato:
Conference item
Publicado:
2008
Existencias
Descripción
Ejemplares similares
Vista Equipo
Descripción
Sumario:
Ejemplares similares
CLINICAL RESPONSE AND PARTIAL REMISSION SUSTAINED THROUGH 3 YEARS OF ADALIMUMAB TREATMENT IN THE ATLAS TRIAL
por: Wordsworth, P, et al.
Publicado: (2009)
Treatment with adalimumab reduces signs and symptoms and induces partial remission in patients with ankylosing spondylitis (AS): 1-year results from ATLAS.
por: van der Heijde, D, et al.
Publicado: (2006)
Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS)
por: van der Heijde, D, et al.
Publicado: (2008)
Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial.
por: Van der Heijde, D, et al.
Publicado: (2005)
Adalimumab enhances health-related quality of life in patients with active ankylosing spondylitis - Results from the atlas trial
por: van der Heijde, D, et al.
Publicado: (2006)